ProShares Ultra Nasdaq Biotechnology Rating $51.52 -1.54 (-2.90%) Closing price 08/5/2025 03:46 PM EasternExtended Trading$51.96 +0.44 (+0.85%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock ProShares Ultra Nasdaq Biotechnology Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BIB Aggregate RatingModerate Buy 2.66Holdings in BIB have an aggregate rating of Moderate Buy based on 361 analyst ratings issued in the past year covering 19 companies (39.0% of the portfolio).BIB Aggregate Price Target$51.52High Prediction$51.52Average Prediction$51.52Low Prediction$51.52Holdings in BIB have an aggregate price target of $51.52 and a range of $51.52 to $51.52 covering 19 companies (39.0% of the portfolio).BIB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ProShares Ultra Nasdaq Biotechnology Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 19 BIB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.10%AMGNAmgen$300.08-0.6%4.596 of 5 stars2.35$307.27 2.4%23Trending NewsEarnings ReportDividend Announcement5.09%VRTXVertex Pharmaceuticals$374.98-20.6%4.8898 of 5 stars2.50$495.21 32.1%26Trending NewsEarnings ReportAnalyst ForecastGap DownHigh Trading Volume5.06%GILDGilead Sciences$112.46-1.8%4.6536 of 5 stars2.81$112.36 -0.1%26Positive NewsUpcoming Earnings4.10%REGNRegeneron Pharmaceuticals$569.90-0.3%4.9106 of 5 stars2.75$832.73 46.1%24Positive NewsEarnings ReportDividend AnnouncementAnalyst Forecast2.97%AZNAstraZeneca$74.48-0.1%3.1581 of 5 stars2.83$89.00 19.5%6Positive NewsAnalyst Revision2.59%ALNYAlnylam Pharmaceuticals$418.91-0.2%3.9118 of 5 stars2.85$396.04 -5.5%27Trending NewsEarnings ReportAnalyst Upgrade1.47%SMMTSummit Therapeutics$29.13-0.6%2.1172 of 5 stars2.79$34.67 19.0%14Positive News1.33%BIIBBiogen$132.89+0.5%4.9158 of 5 stars2.34$185.63 39.7%32Trending NewsEarnings ReportAnalyst Revision1.31%INSMInsmed$111.61+0.3%3.7979 of 5 stars3.00$109.20 -2.2%17Upcoming Earnings1.29%ARGXargenex$674.90-2.2%4.1275 of 5 stars3.10$746.81 10.7%20Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision1.20%ILMNIllumina$97.76-0.7%4.8927 of 5 stars2.40$127.47 30.4%20Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision1.07%RPRXRoyalty Pharma$37.91+0.1%4.9356 of 5 stars3.25$49.00 29.3%4Positive News0.98%SNYSanofi$47.84-0.4%4.369 of 5 stars3.13$62.00 29.6%8Trending NewsEarnings ReportAnalyst Revision0.95%UTHRUnited Therapeutics$304.81+4.2%4.8536 of 5 stars2.69$379.69 24.6%13Trending NewsEarnings ReportAnalyst RevisionHigh Trading Volume0.94%INCYIncyte$77.72-0.4%4.7635 of 5 stars2.28$79.73 2.6%180.91%MRNAModerna$27.47-0.6%4.2603 of 5 stars2.04$45.61 66.0%25Trending NewsEarnings ReportAnalyst Forecast0.91%NBIXNeurocrine Biosciences$128.39+0.3%4.9667 of 5 stars2.86$160.90 25.3%22Trending NewsEarnings ReportAnalyst Revision0.89%MEDPMedpace$436.30+0.9%4.2161 of 5 stars1.93$406.60 -6.8%140.86%EXELExelixis$37.46+1.8%4.9365 of 5 stars2.55$44.44 18.6%22 This page (NASDAQ:BIB) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIB Stock Alerts